Just-in-time CME now easier to utilize

Share this article:
Thanks to technical improvements, a form of online CME may finally realize its potential. Point-of-care (PoC) CME lets doctors earn credit for conducting structured online searches to answer clinical questions.

The format had been hampered by an inability for physicians to easily gain and claim credit online. The paperwork burden of processing half-credit units had posed the “biggest stumbling block” for providers thinking about offering it, said Laird Kelly, president of RSi Communications Group.

A free system Kelly has worked on for the last two years comes wrapped in a browser add-on slated for release next month. It lets physicians enter a query, scour a broad library of resources for answers and claim credit. Subscription-based services, such as UpToDate and Wiley’s InfoPOEMs/InfoRetriever, have added automated processing of credits online. The American College of Physicians told MM&M it is developing a tool to enable for-credit PoC searches with its PIER decision-support tool. Medscape expects to offer a version this year, as well.

Another hurdle had been a lack of credible sources, said Sondra Moylan, founder and president, AACME. Moylan, a joint sponsor of RSi’s search tool, helped assemble a medical advisory board to cull peer-reviewed, evidence-based resources. Other PoC providers employ physicians to write original content.

The AMA and AAFP award PoC credit for a three-step learning cycle: documenting the clinical question, sources consulted and the application to practice.

While industry surveys show a high level of physician interest in PoC, funding for non-subscription services remains an issue.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...